AI Overview
Can't generate an AI overview right now. Try again later.
Breast cancer prognosis when it has spread to lymph nodes varies based on the extent of lymph node involvement and other factors, but generally, survival rates decrease with more extensive lymph node involvement.
Show more
Show less
Early detection and treatment are crucial for a better prognosis.
Factors Influencing Prognosis:
- Number of positive lymph nodes: More positive lymph nodes generally indicate a poorer prognosis.
- Tumor size: Larger tumors are associated with a worse prognosis, regardless of lymph node involvement.
- Lymph node ratio: The ratio of positive lymph nodes to the total number of removed lymph nodes can also be a predictor of survival.
- Tumor grade: Higher-grade tumors (more abnormal cells) tend to have a worse prognosis.
- Hormone receptor status: Hormone receptor-positive tumors (ER+, PR+) may have a better prognosis.
- HER2 status: HER2-positive tumors can be treated with targeted therapies, influencing prognosis.
General Prognosis by Stage (using 5-year survival rates):
- Localized breast cancer (no lymph node involvement): >99% 5-year survival rate.
- Cancer spread to nearby lymph nodes: Around 87% 5-year survival rate, according to Healthline.
- Stage 3 breast cancer (larger tumor, more lymph node involvement): Survival rates vary, but can be around 70-85% or lower, according to Cancer Research UK.
- Stage 4 breast cancer (distant metastasis): 27% 5-year survival rate, according to West Suburban Medical Center.
Important Considerations:
- Individualized prognosis: Survival rates are averages, and individual outcomes can vary.
- Treatment advancements: Modern treatments, especially for advanced stages, can significantly improve survival and quality of life.
- Focus on quality of life: For some, managing breast cancer as a chronic illness with a focus on quality of life is a primary goal.
Disclaimer: This information is for educational purposes only and should not be considered medical advice.
Always consult with a healthcare professional for personalized guidance and treatment recommendations.
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more
Breast cancer that has spread to lymph nodes has a higher risk of coming back and a less favourable prognosis than breast cancer that has not spread to any ...
People also ask
What is the life expectancy of someone with breast cancer in the lymph nodes?
Life expectancy for stage 3 breast cancer. Stage 3 breast cancer is cancer that started in the breast and has spread to nearby lymph nodes. Overall, a person's chance of surviving for 5 years after this diagnosis is around 86%, but this depends on many factors.
Jun 11, 2024
Aug 3, 2022 · Breast cancer that has spread to the lymph nodes is often treatable but may require more aggressive treatment.
The 5-year relative survival rate for Stage 4 breast cancer in men is 20%, according to the American Cancer Society.
The 15-year breast-cancer-specific survival rates for women with medium-sized node-negative cancers was 89%, and for women with medium-sized node-positive ...
Jan 16, 2025 · The SEER database tracks 5-year relative survival rates for breast cancer in the United States, based on how far the cancer has spread.
Lymph node status is highly related to prognosis (chance of survival). Prognosis is better when breast cancer has not spread to the lymph nodes.
Stage 0 and Stage 1 – No spread of cancer outside of the breast and no lymph node involvement = 99% survival rate · Stage 1-3 – Spread to regional lymph nodes = ...
Jun 1, 2013 · Breast cancers with 10 or more positive lymph nodes at the time of diagnosis are staged as pathological N3a (pN3a) and they have poor prognosis.
Jun 11, 2024 · Overall, a person's chance of surviving for 5 years after this diagnosis is around 86%, but this depends on many factors.
Stage 3 breast cancer is treatable and has a 5-year relative survival rate of 87%. Many women with Stage 3 breast cancer will eventually be declared “cancer ...